ECO Animal Health Group (LON:EAH) Earns “Buy” Rating from Shore Capital

ECO Animal Health Group (LON:EAH)‘s stock had its “buy” rating reiterated by research analysts at Shore Capital in a research report issued on Monday, MarketBeat.com reports.

ECO Animal Health Group Trading Down 0.2 %

Shares of EAH opened at GBX 58.36 ($0.76) on Monday. ECO Animal Health Group has a fifty-two week low of GBX 51 ($0.66) and a fifty-two week high of GBX 135 ($1.75). The business has a 50-day moving average of GBX 60.40 and a 200 day moving average of GBX 71.78. The firm has a market cap of £39.54 million, a P/E ratio of 37.73 and a beta of -0.05. The company has a debt-to-equity ratio of 4.81, a quick ratio of 2.14 and a current ratio of 2.96.

ECO Animal Health Group Company Profile

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.